Antibody-drug conjugates (ADCs) represent a particularly important class of drug therapies with specialized effects. They enact their therapeutic benefits by their combination of antibody effects and drug chemistry effects. The antibody portion allows for rapid and very efficient site targeting, and the drug portion allows for a precise insertion of a drug molecule that otherwise couldn’t avoid causing more systemic effects. For example, the linkers between the antibody and drug components allow...